Trials / Completed
CompletedNCT04272216
An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
The RAVI Registry: A Prospective, Multi-Center, Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 99 (actual)
- Sponsor
- Terumo Medical Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This registry study is designed to collect data on the procedural success and complication rates in real-world patients undergoing HydroPearl embolization procedures via radial access.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Treatment with HydroPearl via radial access | This is an observational study collecting data on patients who are already being treated with HydroPearl on-label per standard of care. |
Timeline
- Start date
- 2020-02-06
- Primary completion
- 2022-03-07
- Completion
- 2023-03-11
- First posted
- 2020-02-17
- Last updated
- 2025-09-09
- Results posted
- 2025-09-09
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04272216. Inclusion in this directory is not an endorsement.